Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Readout AI
United States
- Los Angeles, California
- 17/07/2023
- Pre-Seed
- Undisclosed Amount
Readout AI dramatically reduces the time and cost associated with turning raw in-vivo and clinical trial data into insights. Users upload their trial data and the system analyzes it appropriately, running the correct statistical analysis depending on the type of data it infers. It then describes the findings, as tables and paragraphs, automatically. It can even automatically summarize the results in an abstract, plain-language summary, or poster. Readout AI frees scientists to get interpretable results from their data, in seconds.
- Industry Software Development
- Website https://readout.ai/
- LinkedIn https://www.linkedin.com/company/readout-ai/
Related People
Matthew MichelsonFounder
United States -
Pasadena, California
I've been involved with start-ups and Artificial Intelligence/Machine Learning for almost a decade. In that time I've focused both on the practical, helping to launch a number of successful machine-learning-based products, and the academic, publishing numerous peer-reviewed articles in scientific conferences and journals.
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
DataLane | $22,500,000 | (Dec 18, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)